Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LifeSource refers to several active health-related organizations:
LifeSource — A leading U.S. non-profit organ procurement organization serving Minnesota, North Dakota, South Dakota and parts of Wisconsin. It facilitates organ/tissue donation and transplantation through partnerships with hospitals and transplant centers. The organization is highly innovative—implementing AI/data analytics to improve outcomes—and collaborates with academic/research partners to advance transplantation science.[2][5][6]
LifeSource Biomedical Services, LLC — A small U.S.-based preclinical contract research organization located at NASA Ames Research Center in California that provides animal model services including breeding colonies, PK/PD studies, xenograft work and biomedical device testing for investigators in biotech/pharma sectors.[3]
Lifesource Biotechnology Co Ltd — An Asia-based company operating drug stores & pharmacies with limited public information available about its pipeline or R&D focus.[4]
LIFESOURCE PHARMACEUTICALS PRIVATE LIMITED — An Indian pharmaceutical firm established ~1995 based in Mumbai Suburban; details on products/pipeline are unavailable from current sources but it appears active as of June 2024.[7]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LifeSource.